XML 40 R27.htm IDEA: XBRL DOCUMENT v3.22.0.1

Quarterly Financial Data (unaudited)

12 Months Ended

Dec. 31, 2021

Quarterly Financial Data [Abstract]

Quarterly Financial Data (unaudited)

Quarterly Financial Data (unaudited)

As described in Note 3, Roper signed definitive agreements to divest the TransCore, Zetec and CIVCO Radiotherapy businesses. Roper has completed the divestitures of Zetec and CIVCO Radiotherapy, in the first quarter of 2022 and fourth quarter of 2021, respectively, and expects the TransCore transaction to close in the first quarter of 2022. Accordingly, the unaudited interim financial information below has been adjusted to incorporate the presentation of discontinued operations.

			First Quarter						Second Quarter						Third Quarter						Fourth Quarter
2021
Net revenues			$	1,376.1					$	1,426.6					$	1,462.8					$	1,512.3
Gross profit			936.0						967.3						996.1						1,018.0
Income from operations			374.6						381.5						403.5						320.6
Net earnings from continuing operations			269.9						253.0						259.8						199.9
Net earnings from discontinued operations			19.1						33.3						29.7						87.9
Net earnings			289.0						286.3						289.5						287.8
Net earnings per share from continuing operations:
Basic			$	2.57					$	2.40					$	2.47					$	1.90
Diluted			$	2.55					$	2.38					$	2.43					$	1.87
Net earnings per share from discontinued operations:
Basic			$	0.18					$	0.32					$	0.28					$	0.83
Diluted			$	0.18					$	0.31					$	0.28					$	0.83
Net earnings per share:
Basic			$	2.75					$	2.72					$	2.75					$	2.73
Diluted			$	2.73					$	2.69					$	2.71					$	2.70
2020
Net revenues			$	1,182.6					$	1,137.8					$	1,198.2					$	1,335.6
Gross profit			787.5						772.5						809.9						900.9
Income from operations			308.4						291.6						330.5						343.0
Net earnings from continuing operations			209.5						184.0						207.0						225.0
Net earnings from discontinued operations			30.8						35.2						27.4						30.8
Net earnings			240.3						219.2						234.4						255.8
Net earnings per share from continuing operations:
Basic			$	2.01					$	1.76					$	1.98					$	2.15
Diluted			$	1.99					$	1.74					$	1.95					$	2.12
Net earnings per share from discontinued operations:
Basic			$	0.29					$	0.34					$	0.26					$	0.29
Diluted			$	0.29					$	0.34					$	0.26					$	0.29
Net earnings per share:
Basic			$	2.30					$	2.10					$	2.24					$	2.44
Diluted			$	2.28					$	2.08					$	2.21					$	2.41

The sum of the four quarters may not agree with the total for the year due to rounding.

X

- References

No definition available.

+ Details

Name:	us-gaap_QuarterlyFinancialDataAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-URI http://asc.fasb.org/topic&trid=2126967

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=124502072&loc=SL124452896-108306

+ Details

Name:	us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration